✦ LIBER ✦

Evaluation of mineral metabolism and bone turnover in osteoporotic females treated with phosphorus and salmon calcitonin

✍ Scribed by F. P. Cantatore; M. Carrozzo; D. M. Magli; M. D'Amore; V. Pipitone

Publisher: Springer
Year: 1987
Tongue: English
Weight: 326 KB
Volume: 6
Category: Article
ISSN: 0770-3198
DOI: 10.1007/bf02330586

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Total and regional bone mineral content

Total and regional bone mineral content and fracture rate in postmenopausal osteoporosis treated with salmon calcitonin: A prospective study

✍ H. Rico; M. Revilla; E. R. Hernández; L. F. Villa; M. Alvarez Buergo 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 573 KB

Seventy-two postmenopausal osteoporotic women having more than one nontraumatic vertebral crush fracture were studied. Thirty-six of them, aged 68.8 +/- 1.2 years (18 +/- 4 YSM-years since menopause), were treated with 100 IU/day of salmon calcitonin i.m. plus 500 mg of elemental calcium for 10 days

Prevention of bone loss in early nonsurg

Prevention of bone loss in early nonsurgical and nonosteoporotic high turnover patients with salmon calcitonin: The role of biochemical bone markers in monitoring high turnover patients under calcitonin treatment

✍ G. P. Lyritis; B. Magiasis; N. Tsakalakos 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 404 KB

Effect of cyclical therapy with phosphor

Effect of cyclical therapy with phosphorus and etidronate on axial bone mineral density in postmenopausal osteoporotic women

✍ P. D. Miller; B. J. Neal; D. O. McIntyre; M. J. Yanover; M. S. Anger; L. Kowalsk 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 779 KB

Long-term follow-up of bone mineral dens

Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex

✍ P. J. M. van Kesteren; P. Lips; H. Asscheman; J. A. J. Megens; L. J. G. Gooren 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 121 KB

The effect of combined androgen blockade

The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma : Longitudinal evaluation and response to intermittent cyclic etidronate therapy

✍ Terrence Diamond; Joanne Campbell; Carl Bryant; William Lynch 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

## BACKGROUND. Androgen receptor blocking agents have become an established form of therapy for men with disseminated prostate carcinoma. The purpose of this study was to evaluate markers of bone turnover and to measure bone mineral densities (BMD) in men with disseminated prostate carcinoma treat

Total-body bone mineral content in non–c

Total-body bone mineral content in non–corticosteroid-treated postpubertal females with juvenile rheumatoid arthritis: Frequency of osteopenia and contributing factors

✍ Carol J. Henderson; Bonny L. Specker; Rosa I. Sierra; Barbara N. Campaigne; Dani 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 1 views

## Objective: To determine the extent of low total-body bone mineral content (bmc) in non-corticosteroid-treated white postpubertal females with juvenile rheumatoid arthritis (jra) compared with healthy age- and race-matched female controls, and to identify variables that significantly contribute t